260 results on '"Bernardino, M E"'
Search Results
2. Does CTAP prior to hepatic resection improve patient survival rates?
3. Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast.
4. Cost-effective use of low-osmolality contrast media for CT of the liver: evaluation of liver enhancement provided by various doses of iohexol.
5. Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement.
6. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.
7. Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress.
8. Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy.
9. Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography.
10. Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy.
11. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
12. Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Work in progress.
13. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
14. Comparison of iohexol 300 and diatrizoate meglumine 60 for body CT: image quality, adverse reactions, and aborted/repeated examinations.
15. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT.
16. Hepatic pseudolesion: appearance of focal low attenuation in the medial segment of the left lobe at CT arterial portography.
17. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
18. Liver transplant biopsies with a biopsy gun.
19. Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents.
20. Automated biopsy devices: significance and safety.
21. DYNAMIC SEQUENTIAL BOLUS IODINE CT
22. Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography.
23. CT density of mesenteric, retroperitoneal, and subcutaneous fat in cirrhotic patients: comparison with control subjects.
24. Tubo-ovarian abscesses: CT-guided percutaneous drainage.
25. Focal hepatic lesions: comparative MR imaging at 0.5 and 1.5 T.
26. CT and chest radiography are equally sensitive in the detection of pneumothorax after CT-guided pulmonary interventional procedures.
27. Percutaneous needle biopsy of soft tissue tumors guided by ultrasound and computed tomography.
28. Percutaneous needle biopsy in the diagnosis and classification of lymphoma.
29. Accuracy of chest computerized tomography in detecting malignant hilar and mediastinal involvement by squamous cell carcinoma of the lung.
30. The computed tomography-guided adrenal biopsy. An alternative to surgery in adrenal mass diagnosis.
31. A comparison of noninvasive imaging modalities in the melanoma patient.
32. Ultrasonic findings in silicone-augmented breasts.
33. Pancreatic sonography: past and present.
34. Safety and optimum concentration of a manganese chloride-based oral MR contrast agent.
35. Enhancement effects of a hepatocyte receptor-specific MR contrast agent in an animal model.
36. Imaging guided percutaneous hepatic biopsy: diagnostic accuracy and safety.
37. Percutaneous biopsy of pancreatic masses.
38. Magnetic resonance imaging of the liver.
39. Portal-hepatic venous malformation: ultrasound, computed tomographic, and angiographic findings.
40. Comparison of ultrasound and computed tomography in the detection of pancreatic malignancy.
41. The sonographic findings of splenic metastases.
42. Ultrasonic demonstration of inferior vena caval involvement with right adrenal gland masses.
43. Ultrasonography in trophoblastic disease.
44. Direct hepatic tumor injection in rats: can it be used for analysis of MR imaging contrast agent?
45. Monitoring the response of lymphoma patients to therapy: correlation of abdominal CT findings with clinical course and histologic cell type.
46. COMPARISON OF ULTRASOUND AND COMPUTED TOMOGRAPHY IN THE DETECTION OF PANCREATIC MALIGNANCY
47. CT densities in delayed iodine hepatic scanning.
48. Straight line sign: appearance and significance during CT portography.
49. Hepatic sonography: technical considerations, present applications, and possible future.
50. Shunts for portal hypertension: MR and angiography for determination of patency.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.